Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure

Hypertension and heart failure are important contributors to global morbidity and mortality. Despite therapeutic lifestyle and pharmacological measures, a significant proportion of people with hypertension do not reach treatment targets. Patients with resistant or poorly controlled hypertension are...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Anna Meta Dyrvig Kristensen, Manan Pareek, Michael Hecht Olsen, Deepak L Bhatt
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2020
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/c18413c1d55f45098cbe88f8d6572555
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c18413c1d55f45098cbe88f8d6572555
record_format	dspace
spelling	oai:doaj.org-article:c18413c1d55f45098cbe88f8d65725552021-12-04T16:02:19ZBaroreflex Activation Therapy for Resistant Hypertension and Heart Failure10.15420/usc.2019.13.21758-390X1758-3896https://doaj.org/article/c18413c1d55f45098cbe88f8d65725552020-02-01T00:00:00Zhttps://www.uscjournal.com/articleindex/usc.2019.13.2https://doaj.org/toc/1758-3896https://doaj.org/toc/1758-390XHypertension and heart failure are important contributors to global morbidity and mortality. Despite therapeutic lifestyle and pharmacological measures, a significant proportion of people with hypertension do not reach treatment targets. Patients with resistant or poorly controlled hypertension are at significantly increased risk of cardiovascular events, including heart failure. Since dysfunction of the sympathetic nervous system appears to play a key role in the development and progression of both hypertension and heart failure, these patients may benefit from treatment modalities aimed at reducing sympathetic function. The purpose of this paper is to provide an overview of baroreflex activation therapy as a potential treatment strategy in patients with resistant hypertension or heart failure.Anna Meta Dyrvig KristensenManan PareekMichael Hecht OlsenDeepak L BhattRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENUS Cardiology Review , Vol 13, Iss 2, Pp 83-87 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Diseases of the circulatory (Cardiovascular) system RC666-701 Anna Meta Dyrvig Kristensen Manan Pareek Michael Hecht Olsen Deepak L Bhatt Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure
description	Hypertension and heart failure are important contributors to global morbidity and mortality. Despite therapeutic lifestyle and pharmacological measures, a significant proportion of people with hypertension do not reach treatment targets. Patients with resistant or poorly controlled hypertension are at significantly increased risk of cardiovascular events, including heart failure. Since dysfunction of the sympathetic nervous system appears to play a key role in the development and progression of both hypertension and heart failure, these patients may benefit from treatment modalities aimed at reducing sympathetic function. The purpose of this paper is to provide an overview of baroreflex activation therapy as a potential treatment strategy in patients with resistant hypertension or heart failure.
format	article
author	Anna Meta Dyrvig Kristensen Manan Pareek Michael Hecht Olsen Deepak L Bhatt
author_facet	Anna Meta Dyrvig Kristensen Manan Pareek Michael Hecht Olsen Deepak L Bhatt
author_sort	Anna Meta Dyrvig Kristensen
title	Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure
title_short	Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure
title_full	Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure
title_fullStr	Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure
title_full_unstemmed	Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure
title_sort	baroreflex activation therapy for resistant hypertension and heart failure
publisher	Radcliffe Medical Media
publishDate	2020
url	https://doaj.org/article/c18413c1d55f45098cbe88f8d6572555
work_keys_str_mv	AT annametadyrvigkristensen baroreflexactivationtherapyforresistanthypertensionandheartfailure AT mananpareek baroreflexactivationtherapyforresistanthypertensionandheartfailure AT michaelhechtolsen baroreflexactivationtherapyforresistanthypertensionandheartfailure AT deepaklbhatt baroreflexactivationtherapyforresistanthypertensionandheartfailure
_version_	1718372758152282112

Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure

Ejemplares similares